Skip to main content
. 2017 Jul 14;7:5410. doi: 10.1038/s41598-017-05595-4

Figure 1.

Figure 1

HMGCR is over-expressed in ovarian cancer cells and regulated by TP53. (a) The expression of HMGCR was measured by immunoblotting and quantified (b) in a panel of ovarian cancer cells and compared to non-cancerous cells including normal human ovarian epithelia (HOE), human foreskin fibroblasts (HFF) normal lung epithelia (NL20). (c) Wild (WT) and TP53 variants were over-expressed in SkOv-3 cells and p53 and HMGCR measured by immunoblotting. The numbers above the blots show the mean change in protein normalized to GAPDH (n = 3 lysates) and expressed as ratio of that measured in cells transfected with the vector. D. Ovcar-3 cells were transfected with non-targeting (NT) siRNA or 4 different p53 siRNA (#1, #2, #3, #4) and reduction in p53 and HMGCR protein confirmed by immunoblotting (n = 3 independent transfections). Expression was quantified and normalized to that in normal cells (mean ± S.D, n = 3, *paired t-test, P < 0.05, compared to cells transfected with vector). HMGCR mRNA was measured by QPCR, normalized to GAPDH expression and expression was calculated as a fraction of that measured in cells transfected with NT siRNA (paired t-test, n = 3 independent transfections; *P < 0.05; **P < 0.005 compared to cells transfected with NT siRNA). Images presented in this panel were cropped to remove surrounding white space.